Worldwide collaboration for orphan drug designation
- 1 June 2016
- journal article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 15 (6), 440-441
- https://doi.org/10.1038/nrd.2016.80
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Establishing medical plausibility in the context of orphan medicines designation in the European Union.Orphanet Journal of Rare Diseases, 2014
- Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectivesIntractable & Rare Diseases Research, 2012
- European regulation on orphan medicinal products: 10 years of experience and future perspectivesNature Reviews Drug Discovery, 2011
- Kiran Mazumdar-ShawNature Reviews Drug Discovery, 2010
- Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 yearsNature Reviews Drug Discovery, 2010